Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jan;82(2):441-5.
doi: 10.1054/bjoc.1999.0940.

Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro

Affiliations

Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro

M Dettke et al. Br J Cancer. 2000 Jan.

Abstract

Stimulation of monocytes by interaction of monoclonal antibodies (mAbs) with Fc gamma receptors (FcgammaRs) results in the activation of various monocyte effector functions. In the present investigation we show that the anti-Lewis Y (LeY) anti-tumour mAb ABL 364 and its mouse/human IgG1 chimaera induce both antibody-dependent cellular cytotoxicity (ADCC) and the release of tumour necrosis factor alpha (TNF-alpha) during mixed culture of monocytes with LeY+ SKBR5 breast cancer cells in vitro. Although anti-LeY mAb-mediated TNF-alpha release paralleled ADCC activity, cytokine release required a higher concentration of sensitizing mAb than the induction of cytolysis. The determination of the FcgammaR classes involved in the induction of the distinct effector functions showed that anti-LeY mAb-induced cytolysis was triggered by interaction between anti-LeY mAbs and FcgammaRI. In contrast, mAb-induced TNF-alpha release mainly depended on the activation of monocyte FcgammaRII. Neutralization of TNF-alpha showed no influence on monocyte ADCC activity towards SKBR5 target cells. Our data indicate an independent regulation of anti-LeY mAb induced effector functions of ADCC and TNF-alpha release which seemed to be triggered by activation of different types of FcgammaR.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem J. 1977 Nov 15;168(2):187-94 - PubMed
    1. Cancer Immunol Immunother. 1998 Jun;46(4):213-20 - PubMed
    1. J Biol Chem. 1987 Jan 5;262(1):372-9 - PubMed
    1. J Immunol. 1988 May 15;140(10):3467-72 - PubMed
    1. J Natl Cancer Inst. 1988 Dec 7;80(19):1553-9 - PubMed

Publication types